Gut Microbiota as a Therapeutic Target for Metabolic Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|25|9|984-1001

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.25, Iss.9, 2018-03, pp. : 984-1001

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target

By  

Current Pharmaceutical Design, Vol. 19, Iss. 29, 2013-09 ,pp. : 5314-5324

Bentham Science Publishers

Access to resources Recommend Favorite

The Histamine H3 Receptor as a Therapeutic Drug Target for Metabolic Disorders: Status, Challenges and Opportunities

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1430-1446

Bentham Science Publishers

Access to resources Recommend Favorite

The Gut Microbiota as a Target for Improved Surgical Outcome and Improved Patient Care

By  

Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. : 1537-1545

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: Gut Microbiota and Brain Function: A New Target for Brain Diseases?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 733-735

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of the Maturing Gut Barrier and Microbiota: A Novel Target in Allergic Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 14, 2008-01 ,pp. : 1368-1375

Bentham Science Publishers

Access to resources Recommend Favorite